Diaceutics (LON:DXRX) Insider Purchases £149.76 in Stock

Diaceutics PLC (LON:DXRX) insider Jordan Clark bought 117 shares of the firm’s stock in a transaction on Tuesday, December 23rd. The stock was acquired at an average price of GBX 128 per share, for a total transaction of £149.76.

Diaceutics Price Performance

DXRX stock opened at GBX 129 on Friday. The company has a 50 day simple moving average of GBX 151.60 and a 200 day simple moving average of GBX 142.17. The stock has a market cap of £109.17 million, a price-to-earnings ratio of -71.67 and a beta of 0.58. Diaceutics PLC has a 1 year low of GBX 106 and a 1 year high of GBX 168. The company has a debt-to-equity ratio of 0.39, a current ratio of 4.85 and a quick ratio of 9.92.

Diaceutics (LON:DXRX) last released its quarterly earnings data on Tuesday, September 23rd. The company reported GBX (2.84) earnings per share (EPS) for the quarter. Diaceutics had a negative net margin of 10.90% and a negative return on equity of 7.15%. Research analysts anticipate that Diaceutics PLC will post 1.0107919 EPS for the current fiscal year.

Diaceutics Company Profile

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.